TY - JOUR
T1 - Cost-Effectiveness of Peer- Versus Venue-Based Approaches for Detecting Undiagnosed HIV Among Heterosexuals in High-Risk New York City Neighborhoods
AU - Stevens, Elizabeth R.
AU - Nucifora, Kimberly A.
AU - Zhou, Qinlian
AU - Braithwaite, Ronald Scott
AU - Cleland, Charles M.
AU - Ritchie, Amanda S.
AU - Kutnick, Alexandra H.
AU - Gwadz, Marya V.
N1 - Funding Information:
Received for publication June 13, 2017; accepted October 13, 2017. From the *Department of Population Health, NYU School of Medicine, New York, NY; and †Center for Drug Use and HIV Research, Rory Meyers College of Nursing, New York University, New York, NY. Supported by the National Institute on Drug Abuse (R01DA032083) and the Center for Drug Use and HIV Research (CDUHR; P30 DA011041; Sherry Deren, PhD and Holly Hagan, PhD, Co-Principal Investigators). The authors have no conflicts of interest to disclose. Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.jaids.com). Correspondence to: Elizabeth R. Stevens, MPH, Department of Population Health, New York University School of Medicine, 227 E. 30th Street, New York, NY 10016 (e-mail: Elizabeth.stevens@nyumc.org). Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.
Publisher Copyright:
Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2018/2/1
Y1 - 2018/2/1
N2 - Introduction: We used a computer simulation of HIV progression and transmission to evaluate the cost-effectiveness of a scale-up of 3 strategies to seek out and test individuals with undiagnosed HIV in New York City (NYC). Setting: Hypothetical NYC population. Methods: We incorporated the observed effects and costs of the 3 “seek and test” strategies in a computer simulation of HIV in NYC, comparing a scenario in which the strategies were scaled up with a 1-year implementation or a long-term implementation with a counter-factual scenario with no scale-up. The simulation combined a deterministic compartmental model of HIV transmission with a stochastic microsimulation of HIV progression, calibrated to NYC epidemiological data from 2003 to 2015. The 3 approaches were respondent-driven sampling (RDS) with anonymous HIV testing (“RDS-A”), RDS with a 2-session confidential HIV testing approach (“RDS-C”), and venue-based sampling (“VBS”). Results: RDS-A was the most cost-effective strategy tested. When implemented for only 1 year and then stopped thereafter, using a societal perspective, the cost per quality-adjusted life-year (QALY) gained versus no intervention was $812/QALY, $18,110/QALY, and $20,362/QALY for RDS-A, RDS-C, and VBS, respectively. When interventions were implemented long term, the cost per QALY gained versus no intervention was cost-saving, $31,773/ QALY, and $35,148/QALY for RDS-A, RDS-C, and VBS, respectively. When compared with RDS-A, the incremental cost-effectiveness ratios for both VBS and RDS-C were dominated. Conclusions: The expansion of the RDS-A strategy would substantially reduce HIV-related deaths and new HIV infections in NYC, and would be either cost-saving or have favorable cost-effectiveness.
AB - Introduction: We used a computer simulation of HIV progression and transmission to evaluate the cost-effectiveness of a scale-up of 3 strategies to seek out and test individuals with undiagnosed HIV in New York City (NYC). Setting: Hypothetical NYC population. Methods: We incorporated the observed effects and costs of the 3 “seek and test” strategies in a computer simulation of HIV in NYC, comparing a scenario in which the strategies were scaled up with a 1-year implementation or a long-term implementation with a counter-factual scenario with no scale-up. The simulation combined a deterministic compartmental model of HIV transmission with a stochastic microsimulation of HIV progression, calibrated to NYC epidemiological data from 2003 to 2015. The 3 approaches were respondent-driven sampling (RDS) with anonymous HIV testing (“RDS-A”), RDS with a 2-session confidential HIV testing approach (“RDS-C”), and venue-based sampling (“VBS”). Results: RDS-A was the most cost-effective strategy tested. When implemented for only 1 year and then stopped thereafter, using a societal perspective, the cost per quality-adjusted life-year (QALY) gained versus no intervention was $812/QALY, $18,110/QALY, and $20,362/QALY for RDS-A, RDS-C, and VBS, respectively. When interventions were implemented long term, the cost per QALY gained versus no intervention was cost-saving, $31,773/ QALY, and $35,148/QALY for RDS-A, RDS-C, and VBS, respectively. When compared with RDS-A, the incremental cost-effectiveness ratios for both VBS and RDS-C were dominated. Conclusions: The expansion of the RDS-A strategy would substantially reduce HIV-related deaths and new HIV infections in NYC, and would be either cost-saving or have favorable cost-effectiveness.
KW - Cost-effectiveness
KW - HIV testing
KW - Health disparities
KW - Heterosexuals
KW - Respondent-driven sampling
KW - Undiagnosed HIV
KW - Venue-based sampling
UR - http://www.scopus.com/inward/record.url?scp=85045856669&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85045856669&partnerID=8YFLogxK
U2 - 10.1097/QAI.0000000000001578
DO - 10.1097/QAI.0000000000001578
M3 - Article
C2 - 29135654
AN - SCOPUS:85045856669
SN - 1525-4135
VL - 77
SP - 183
EP - 192
JO - Journal of Acquired Immune Deficiency Syndromes
JF - Journal of Acquired Immune Deficiency Syndromes
IS - 2
ER -